This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.


Hydrogel Delivery of Neural Growth Factors and Stem Cells for the Treatment of Spinal Cord Injuries

Seminar Center for Excellence in the Neurosciences Seminar Series

Stephan Lindsay, Ph.D.

COBRE Pilot Project Investigator & Post Doc Research Fellow, Alfred I. duPont Hospital for Children, Nemours Center for Pediatric Research

Current Research in the Laboratory:
To improve the outcome for children diagnosed with brain tumors, including medulloblastoma, the Cancer Epigenetics Lab, headed by Sigrid A. Langhans, PhD, is taking three complementary approaches to its pediatric cancer research:

  1. Curcumin Research
  2. Nanotechnology-based Approaches for Improved Drug Delivery to the Brain 
    To circumvent the blood-brain barrier, a natural impediment for efficient drug delivery to the brain, researchers at the Cancer Epigenetics lab are developing, in collaboration with the Department of Materials Science and Engineering at the University of Delaware, a nano-hydrogel approach for direct drug delivery to brain tumors. Initial studies confirmed that the hydrogels are suitable drug carriers with a sustained drug release profile. The project was supported by the Center of Biomedical Research Excellence (COBRE) at the University of Delaware.
  3. Novel Drug Targets

Lunch will be provided.

Host: Ling Cao, MD, PhD


Center for Excellence in Neurosciences


12:00 PM
Alfond Room 304

Biddeford Campus

Free and open to the public